Slow growth forecast for asthma therapeutics market to 2018
The global asthma therapeutics market was valued at $14.4 billion in 2010, and is forecast to grow at a compound annual growth rate (CAGR) of 4.6% over the next eight years, to reach $20.6 billion by 2018, according to a new report from GlobalData.
The asthma therapeutics market has registered high growth during 2005 to 2010. This is due to the growth in the patient population during 2005-2010 as well as the preferential uptake of novel products such as Advair/Seretide and Symbicort; the global asthma therapeutics market grew at a compound annual growth rate (CAGR) of 11.2% between 2005 and 2010.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
| Headless Content Management with Blaze